Natco Pharma slips on USFDA observations

Shares of Natco Pharmaceutical slumped 11 per cent on Monday after the US Food and Drug Regulator issued two observations regarding company's facilities in Chennai and Hyderabad.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved